

9:00 am EDT - 2:00 pm EDT
Past Event
9:00 am - 2:00 pm EDT
1775 Massachusetts Avenue, NW
Washington, DC
20036
As part of ongoing cooperative work with the U.S. Food and Drug Administration, the Engelberg Center for Health Care Reform has formed a council to bring together expert perspectives on the challenges facing antibacterial drug development. Designed to include representatives from academia, patient advocacy groups, industry, providers, and government agencies, the Brookings Council on Antibacterial Drug Development (BCADD), will convene twice a year to discuss pressing issues in the treatment of infectious diseases and potential steps to address them.
The first BCADD meeting, held on August 30, 2012, brought stakeholders together to discuss the following:
For more information on FDA’s Antibacterial Drug Development Task Force, click here.
9:00 am - 9:45 am
9:45 am - 10:45 am
11:00 am - 12:00 pm
12:30 pm - 1:45 pm
Gerard F. Anderson, Richard G. Frank, Benjamin Rome
November 21, 2023
Richard G. Frank, Fiona Scott Morton, Aaron Kesselheim, Gerard F. Anderson, Rena M. Conti, David M. Cutler, Jack Hoadley
October 27, 2023
Richard G. Frank, Fiona Scott Morton, Aaron Kesselheim, Gerard F. Anderson, Rena M. Conti, David M. Cutler, Jack Hoadley
October 27, 2023